On January 7, 2011
Inside GSK’s $1.1B Kafka-esque Diabetes Nightmare
The evidence GSK needs does not exist, and it is now impossible to get. Worse, the evidence GSK was asked to gather is now being used against it.
No tags for this post.
0 Comments